Treatment of Experimental Choroidal Neovascularization via RUNX1 Inhibition-Reference-Cited by-同舟云学术

Treatment of Experimental Choroidal Neovascularization via RUNX1 Inhibition

Published:2021-03 Issue:3 Volume:191 Page:418-424
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Gonzalez-Buendia Lucia,Delgado-Tirado Santiago,An Miranda^ORCID,O'Hare Michael,Amarnani Dhanesh^ORCID,A.B. Whitmore Hannah^ORCID,Zhao Guannan,Ruiz-Moreno Jose M.^ORCID,Arboleda-Velasquez Joseph F.,Kim Leo A.^ORCID

Funder

E. Matilda Ziegler Foundation for the Blind

National Institute of Neurological Disorders and Stroke

Karl Kirchgessner Foundation

Fundación Alfonso Martín Escudero

National Eye Institute

National Institute on Aging

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference26 articles.

1. Intraretinal cysts are the most relevant prognostic biomarker in neovascular age-related macular degeneration independent of the therapeutic strategy;Ritter;Br J Ophthalmol,2014

2. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration;Schmidt-Erfurth;Ophthalmology,2015

3. Ranibizumab versus verteporfin for neovascular age-related macular degeneration;Brown;N Engl J Med,2006

4. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N Engl J Med,2006

5. Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP);Rofagha;Ophthalmology,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RUNX1 is Expressed in a Subpopulation of Dermal Fibroblasts and Higher RUNX1 Levels are Associated with the Severity of Systemic Sclerosis;2024-04-05

2. Aberrant SUMO2/3 modification of RUNX1 upon SENP1 inhibition is linked to the development of diabetic retinopathy in mice;Experimental Eye Research;2023-12

3. Combination of RUNX1 inhibitor and gemcitabine mitigates chemo‐resistance in pancreatic ductal adenocarcinoma by modulating BiP/PERK/eIF2α-axis-mediated endoplasmic reticulum stress;Journal of Experimental & Clinical Cancer Research;2023-09-11

4. RUN(X) out of blood: emerging RUNX1 functions beyond hematopoiesis and links to Down syndrome;Human Genomics;2023-09-05

5. Combination of RUNX1 inhibitor and gemcitabine to mitigate chemo‐resistance in pancreatic ductal adenocarcinoma by modulating BiP/PERK/eIF2a-axis-mediated endoplasmic reticulum stress;2023-05-23